-
Mashup Score: 5percy lee metabolic tumor volume - Search Results - PubMed - 1 month(s) ago
percy lee metabolic tumor volume – Search Results – PubMed
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Fostering Collaboration Between Clinicians and Computers - 2 month(s) ago
In this Viewpoint, Verghese and colleagues discuss the promise and challenges of integrating artificial intelligence (AI) into clinical care and argue that AI will always need guidance by physicians if it is to improve the care of patients.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
In some form or fashion, we’re all aware of what adaptive radiotherapy (ART) is. You’ve probably treated a head and neck patient whose tumor responds quickly to radiation. Or a patient that loses weight during their course and requires a replan. But there’s more to it than the occasional mid-course replan. If it’s a trendy topic now, it’s not because it’s new to the scene. Making changes to plans during a course of treatment has been common for decades, but now it’s back in the spotlight (*ahem*, FLASH
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 332024 RSS Annual Meeting - 3 month(s) ago
March 21-23, 2024Fairmont Millennium Park200 North Columbus DriveChicago, IL, 60601 The 2024 Radiosurgery Society® (RSS) Scientific Meeting Meeting is a collaborative, multi-disciplinary conference, bringing together world-class healthcare professionals who are passionate about the ongoing advancements of stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT) and advancing…
Source: www.rssevents.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Accelerated Hypofractionated Chemoradiation and Stereotactic Ablative Radiotherapy Boost for NSCLC - 4 month(s) ago
This nonrandomized controlled trial aims to determine the maximum tolerated dose and use of hypofractionated concurrent chemoradiation with an adaptive stereotactic ablative radiotherapy boost for patients with locally advanced, unresectable non–small cell lung cancer (NSCLC).
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12Accelerated Hypofractionated Chemoradiation and Stereotactic Ablative Radiotherapy Boost for NSCLC - 4 month(s) ago
This nonrandomized controlled trial aims to determine the maximum tolerated dose and use of hypofractionated concurrent chemoradiation with an adaptive stereotactic ablative radiotherapy boost for patients with locally advanced, unresectable non–small cell lung cancer (NSCLC).
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 312024 RSS Annual Meeting - 5 month(s) ago
March 21-23, 2024Fairmont Millennium Park200 North Columbus DriveChicago, IL, 60601 The 2024 Radiosurgery Society® (RSS) Scientific Meeting Meeting is a collaborative, multi-disciplinary conference, bringing together world-class healthcare professionals who are passionate about the ongoing advancements of stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT) and advancing…
Source: www.rssevents.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Percy Lee: One aspect of authentic leadership is... - Oncodaily | Oncology News, Insights, Stories - 5 month(s) ago
Percy Lee, Professor and Vice-Chair of Clinical Research at City of Hope, shared on LinkedIn:
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Percy Lee: No other radiation oncology in market can do this - Oncodaily | Oncology News, Insights, Stories - 5 month(s) ago
Percy Lee, Professor and Vice-Chair of Clinical Research at City of Hope, shared on Twitter:
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21City of Hope logo - 5 month(s) ago
Physician Assistant – Radiation Oncology job
Source: www.cityofhopejobs.orgCategories: General Medicine News, Hem/OncsTweet
3/n Many of us in the 2009-2015 showed NSCLC metabolic tumor volume is highly prognostics across stages I-IV and drive OS and PFS. I don't think that has changed today. @BLoo_LT_SABR @Qle_stanford See these articles as examples demonstrating this: https://t.co/JXP0dGjt46